Mercator gets $6.5M boost to market microinfusion devices

05/31/2013 | (Boston)

Mercator MedSystems has obtained $6.5 million in a Series B financing round, which it will use in part to begin sales of its Cricket and Bullfrog microinfusion devices in the U.S., Europe and Australia. The devices, which already have FDA clearance and CE mark approval in Europe, are used to safely deliver drugs to deep tissue through blood vessel walls.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ